MidFirst Bank’s Zimmer Biomet ZBH Stock Holding History

MidFirst Bank’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13	Closed	-$1.17K	–	1013
2025 Q4	$1.17K	Buy	+13	New	+$1.23K	﹤0.01%	704

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MidFirst Bank's ZBH Position: Q1 2026 in Review

MidFirst Bank sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 13 shares — an estimated $1.17K sold.

MidFirst Bank first reported a position in ZBH in Q4 2025 and held it in 1 quarter. The position peaked at $1.17K in Q4 2025. 915 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

MidFirst Bank reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
MidFirst Bank sold 13 Zimmer Biomet shares in Q1 2026, an estimated $1.17K.
MidFirst Bank first reported a position in Zimmer Biomet in Q4 2025 and held it in 1 quarter.
MidFirst Bank's Zimmer Biomet position peaked at $1.17K in Q4 2025.
915 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on MidFirst Bank's 13F filing for Q1 2026, filed 15 May 2026.